Dr. Dongfeng Qu is an Assistant Professor in the Department of Medicine and Associate member in Oklahoma Stephenson Cancer Center at University of Oklahoma Health Sciences Center, USA. She has a broad background in Pancreatic and Colon cancer biology, experimental therapeutics with extensive training and experience in molecular and cellular biology and animal models relevant to the background knowledge. Her research mainly focuses on targeted therapies for pancreas and colon cancer treatment. She is a member of the American Association of Cancer Research and member of American Pancreatic Association.
Testing novel small molecule inhibitors for Pancreatic and Colon cancer treatment. Characterizing and developing novel treatment strategies to reduce cancer recurrence. KR as signaling activation in solid tumors and targeting the PTM of KR as a novel treatment strategy to enhance the sensitivity of cancer cells for chemotherapy.